About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mesenteric Infiltration in Ovarian Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06331130

Mesenteric Infiltration in Ovarian Cancer

To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the ...

Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Camilla Panico, Dr

CONTACT

+390630155701 camilla.panico@policlinicogemelli.it

Sponsors

Lead Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborators

Danube University Krems
Institut du Cancer de Montpellier - Val d'Aurelle
Ente Ospedaliero Cantonale, Ticino, Switzerland

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Women with confirmed HGSOC wiht mesenteric involvment
•2. Age \> 18 years
•3. FIGO STAGE IIIB-IV
•4. Primary diagnosis
•5. Signed informed consent

Exclusion Criteria

•1. Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer)
•2. Early stage disease (I and II stage)
•3. CT scan not available
•4. Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy

Related studies

RECRUITINGPhase 1

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

NCT06964009 · Ovarian Cancer, Ovarian Carcinoma, and more

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

NCT05990426 · Ovary Cancer, Endometrial Cancer, and more

RECRUITINGPhase 1/2

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695 · Solid Tumor, Adult, Colorectal Cancer, and more

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

NCT06800105 · Ovary Cancer

RECRUITINGPhase 2

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

NCT05080556 · Ovarian Cancer, Relapsed Ovarian Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 12, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment510

Start dateMar 2024

Last updatedMar 12, 2025

Condition

Locations shown

Advanced Radiology Center

Roma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions